Diabetes and dyslipidemia: characterizing lipoprotein metabolism

Diabetes and dyslipidemia: characterizing lipoprotein metabolism

GH Tomkin,1,2 D Owens1,2 1Diabetes Institute of Ireland, Beacon Hospital, 2Trinity College, University of Dublin, Dublin, Ireland Abstract: Premature atherosclerosis in diabetes accounts for much of the decreased life span. New treatments have reduced this risk considerably. This review explores the...

Full description

Bibliographic Details
Main Authors: Tomkin GH, Owens D
Format: Article
Language:English
Published: Dove Medical Press 2017-07-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
Obesity
type 2 diabetes
dyslipidaemia
low density lipoprotein LDL
fibroblast growth (factor FGF) forkhead transcription factor (FOX)O1
farnesyl X transcription factors (FRX)
Online Access:https://www.dovepress.com/diabetes-and-dyslipidemia-characterizing-lipoprotein-metabolism-peer-reviewed-article-DMSO

Internet

https://www.dovepress.com/diabetes-and-dyslipidemia-characterizing-lipoprotein-metabolism-peer-reviewed-article-DMSO

Similar Items